AQR Capital Management LLC Acquires 496,069 Shares of Sotera Health (NASDAQ:SHC)

AQR Capital Management LLC raised its holdings in shares of Sotera Health (NASDAQ:SHC) by 3,198.2% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 511,580 shares of the company’s stock after purchasing an additional 496,069 shares during the period. AQR Capital Management LLC’s holdings in Sotera Health were worth $6,072,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in SHC. CWM LLC grew its stake in shares of Sotera Health by 86.1% in the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after buying an additional 993 shares during the last quarter. Swiss National Bank boosted its holdings in Sotera Health by 0.5% in the first quarter. Swiss National Bank now owns 195,900 shares of the company’s stock worth $2,353,000 after acquiring an additional 1,000 shares in the last quarter. TD Asset Management Inc increased its holdings in shares of Sotera Health by 1.5% during the second quarter. TD Asset Management Inc now owns 123,454 shares of the company’s stock valued at $1,465,000 after acquiring an additional 1,800 shares in the last quarter. Securian Asset Management Inc. increased its holdings in shares of Sotera Health by 23.0% during the first quarter. Securian Asset Management Inc. now owns 10,178 shares of the company’s stock valued at $122,000 after acquiring an additional 1,900 shares in the last quarter. Finally, State of Alaska Department of Revenue raised its position in shares of Sotera Health by 20.6% in the 1st quarter. State of Alaska Department of Revenue now owns 13,490 shares of the company’s stock worth $162,000 after purchasing an additional 2,300 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Sotera Health Price Performance

NASDAQ SHC opened at $15.80 on Friday. The company has a debt-to-equity ratio of 5.46, a quick ratio of 2.59 and a current ratio of 2.93. The company has a market capitalization of $4.47 billion, a price-to-earnings ratio of 83.16 and a beta of 2.07. The stock has a 50-day moving average of $15.51 and a 200 day moving average of $13.02. Sotera Health has a one year low of $10.71 and a one year high of $17.44.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Monday, August 5th. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.04. The firm had revenue of $277.00 million during the quarter, compared to analysts’ expectations of $266.45 million. Sotera Health had a net margin of 3.65% and a return on equity of 47.26%. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.19 earnings per share. On average, sell-side analysts forecast that Sotera Health will post 0.64 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. Barclays increased their price objective on shares of Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a research report on Tuesday, August 6th. Royal Bank of Canada reiterated an “outperform” rating and set a $17.00 price target on shares of Sotera Health in a report on Tuesday, August 6th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, Sotera Health has an average rating of “Moderate Buy” and a consensus price target of $15.70.

Insider Buying and Selling at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction on Friday, September 6th. The stock was sold at an average price of $15.03, for a total value of $150,300,000.00. Following the completion of the sale, the director now owns 49,215,301 shares of the company’s stock, valued at $739,705,974.03. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 55.12% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.